MN Pharmaceuticals Raises The Bar In Occupational Safety

MN Pharmaceuticals, one of the leader companies in Turkish pharmaceutical industry, was awarded the OHSAS 18001 Occupational Health and Safety certificate.

April 16, 2009, Istanbul. MN Pharmaceuticals, one of the leaders and most established companies of the Turkish pharmaceutical industry, has lifted the occupational safety standards to the top in its pharmaceutical production plants located in Yenibosna and was awarded the OHSAS 18001 Occupational Health and Safety certificate. The certificate was presented to MN by the British Management Systems Organization BSI.

MN Pharmaceuticals, with its 1,100 specialized personnel and modern plants, is one of the leaders in finished pharmaceutical product and pharmaceutical raw material producers in Turkey. The company produces basic pharmaceutical forms such as ampoule, vial, lyophilized injection, capsule, tablet, film-coated tablet, dry powder and suspension in its four different production units located in Yenibosna.

Levent Selamoglu, MN Pharmaceuticals CEO, said that it is a source of motivation to get the rewards for the investments they have placed in occupational health and safety especially in a time when the economical crisis is effective and continued as follows:

‘’We place great emphasis on and invest in improving all our standards ranging from environmental to occupational health and safety in our facilities which are amongst the outstanding production plants of the Turkish pharmaceutical sector. Recently our efforts have been rewarded with OHSAS 18001 Occupational Health and Safety certificate. This certificate has been an important source of motivation for us especially in this crisis atmosphere. We will continue our work to improve our production standards in our facilities.